Healthpeak Properties (NYSE:DOC) Stock Price Expected to Rise, Mizuho Analyst Says

Healthpeak Properties (NYSE:DOC) had its target price upped by equities research analysts at Mizuho from $21.00 to $24.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Mizuho’s price target indicates a potential upside of 9.82% from the company’s current price.

A number of other analysts have also commented on DOC. Robert W. Baird boosted their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price on the stock. in a research report on Monday, May 11th. Wells Fargo & Company lifted their target price on Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research report on Monday, June 1st. Scotiabank increased their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Finally, Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Four equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $20.19.

Healthpeak Properties Stock Down 0.2%

Shares of NYSE DOC opened at $21.85 on Monday. The stock has a market capitalization of $15.07 billion, a P/E ratio of 68.30, a P/E/G ratio of 3.41 and a beta of 1.02. The company has a 50-day moving average price of $19.54 and a 200-day moving average price of $17.85. Healthpeak Properties has a 1 year low of $15.70 and a 1 year high of $21.98. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. During the same quarter in the prior year, the business posted $0.46 EPS. The firm’s revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, equities research analysts forecast that Healthpeak Properties will post 1.75 EPS for the current fiscal year.

Insider Buying and Selling

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This trade represents a 59.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Healthpeak Properties

Several institutional investors have recently modified their holdings of the business. WPG Advisers LLC boosted its position in Healthpeak Properties by 270.2% in the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after purchasing an additional 1,197 shares during the last quarter. Advocate Investing Services LLC bought a new position in Healthpeak Properties in the 4th quarter valued at $26,000. Elyxium Wealth LLC purchased a new stake in shares of Healthpeak Properties during the 4th quarter valued at $31,000. Clearstead Advisors LLC increased its position in shares of Healthpeak Properties by 166.3% during the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 1,216 shares during the last quarter. Finally, CYBER HORNET ETFs LLC bought a new position in Healthpeak Properties during the second quarter valued at about $33,000. 93.57% of the stock is owned by institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.